Protective Effects of Vitamin C and L-Carnitine on Moxifloxacin-Induced Nephrotoxicity in Rats
Abstract
Moxifloxacin is an essential clinically relevant fluoroquinolone antibiotic that is employed against a great variety of bacterial infections. Nevertheless, its use in clinical practice is linked to nephrotoxicity that is a severe adverse outcome that involves oxidative stress pathways. This paper sought to compare the ameliorative property of two strong antioxidants, Vitamin C and L-Carnitine, to moxifloxacin induced renal injury on a male albino rat model. The rat population was randomly divided into four groups of ten (i.e. a control group, a group treated with moxifloxacin (80 mg/kg), a group treated with moxifloxacin and Vitamin C (500 mg/kg) and a group treated with moxifloxacin and L-Carnitine (600 mg/kg). All therapies were taken in the form of gavage every day and in 30 days. To evaluate the renal damage, the serum urea and creatinine levels were measured, and kidney tissues were examined histopathologically to observe structural changes in tissues. The findings revealed that the serum levels of urea and creatinine were highly increased in moxifloxacin treated rats in isolation of the control group and signified poor kidney functioning. Histopathological analysis showed severe renal injury, such as shrinkage of the glomeruli, tubular necrosis, inflammation of the tissue by cells and cytoarchitectural degeneration. Inflammation and cellular injury were measured using systematic histopathological scoring of tissue sections to measure glomerular integrity, extent…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.